Tag Archives: Available

Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org


Dallas, Texas (PRWEB) September 17, 2014

“North America Gynecological Devices Market Outlook to 2020″, provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments –

Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings))
Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices)
Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge)
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available.

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10486 .

The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Complete Report Details Available @ http://www.marketoptimizer.org/north-america-gynecological-devices-market-outlook-to-2020.html .

Overview of Key Companies in North America Gynecological Devices Market:

Conceptus, Inc.
Hologic, Inc.
Boston Scientific Corporation
Cook Group Incorporated
CooperSurgical, Inc.
Merit Medical Systems, Inc.
Utah Medical Products, Inc.
Johnson & Johnson
BSD Medical Corporation
Scope

Market size data for Gynecological Devices market segments – Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge).
Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
2013 company shares and distribution shares data for Gynecological Devices market.
Global corporate-level profiles of key companies operating within the Gynecological Devices market.
Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical.
Reasons to buy

Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=10486 . (This is a premium report priced at US$ 3000 for a single user License.)

Major Points in Table of Content

3 Gynecological Devices Market, North America

3.1 Gynecological Devices Market, North America, Revenue ($ m), 2005-2020

3.2 Gynecological Devices Market, North America, Category Comparison by Revenue ($ m), 2005-2020

3.3 Gynecological Devices Market, North America, Revenue ($ m), 2005-2013

3.4 Gynecological Devices Market, North America, Revenue ($ m), 2013-2020

3.5 Gynecological Devices Market, North America, Volume (Units), 2005-2020

3.6 Gynecological Devices Market, North America, Volume (Units), 2005-2013

3.7 Gynecological Devices Market, North America, Volume (Units), 2013-2020

3.8 Gynecological Devices Market, North America, Company Share by Revenue ($ m), 2012-2013

4 Gynecological Devices Market, Canada

5 Gynecological Devices Market, Mexico

6 Gynecological Devices Market, United States

Explore more reports on Medical Devices industry at http://www.marketoptimizer.org/category/life-sciences/medical-devices .

About Us:

MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.







Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org


Dallas, Texas (PRWEB) September 17, 2014

“North America Gynecological Devices Market Outlook to 2020″, provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments –

Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings))
Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices)
Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge)
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available.

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10486 .

The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Complete Report Details Available @ http://www.marketoptimizer.org/north-america-gynecological-devices-market-outlook-to-2020.html .

Overview of Key Companies in North America Gynecological Devices Market:

Conceptus, Inc.
Hologic, Inc.
Boston Scientific Corporation
Cook Group Incorporated
CooperSurgical, Inc.
Merit Medical Systems, Inc.
Utah Medical Products, Inc.
Johnson & Johnson
BSD Medical Corporation
Scope

Market size data for Gynecological Devices market segments – Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge).
Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
2013 company shares and distribution shares data for Gynecological Devices market.
Global corporate-level profiles of key companies operating within the Gynecological Devices market.
Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical.
Reasons to buy

Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=10486 . (This is a premium report priced at US$ 3000 for a single user License.)

Major Points in Table of Content

3 Gynecological Devices Market, North America

3.1 Gynecological Devices Market, North America, Revenue ($ m), 2005-2020

3.2 Gynecological Devices Market, North America, Category Comparison by Revenue ($ m), 2005-2020

3.3 Gynecological Devices Market, North America, Revenue ($ m), 2005-2013

3.4 Gynecological Devices Market, North America, Revenue ($ m), 2013-2020

3.5 Gynecological Devices Market, North America, Volume (Units), 2005-2020

3.6 Gynecological Devices Market, North America, Volume (Units), 2005-2013

3.7 Gynecological Devices Market, North America, Volume (Units), 2013-2020

3.8 Gynecological Devices Market, North America, Company Share by Revenue ($ m), 2012-2013

4 Gynecological Devices Market, Canada

5 Gynecological Devices Market, Mexico

6 Gynecological Devices Market, United States

Explore more reports on Medical Devices industry at http://www.marketoptimizer.org/category/life-sciences/medical-devices .

About Us:

MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.







Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org


Dallas, Texas (PRWEB) September 17, 2014

“North America Gynecological Devices Market Outlook to 2020″, provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments –

Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings))
Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices)
Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge)
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available.

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10486 .

The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Complete Report Details Available @ http://www.marketoptimizer.org/north-america-gynecological-devices-market-outlook-to-2020.html .

Overview of Key Companies in North America Gynecological Devices Market:

Conceptus, Inc.
Hologic, Inc.
Boston Scientific Corporation
Cook Group Incorporated
CooperSurgical, Inc.
Merit Medical Systems, Inc.
Utah Medical Products, Inc.
Johnson & Johnson
BSD Medical Corporation
Scope

Market size data for Gynecological Devices market segments – Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge).
Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
2013 company shares and distribution shares data for Gynecological Devices market.
Global corporate-level profiles of key companies operating within the Gynecological Devices market.
Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical.
Reasons to buy

Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=10486 . (This is a premium report priced at US$ 3000 for a single user License.)

Major Points in Table of Content

3 Gynecological Devices Market, North America

3.1 Gynecological Devices Market, North America, Revenue ($ m), 2005-2020

3.2 Gynecological Devices Market, North America, Category Comparison by Revenue ($ m), 2005-2020

3.3 Gynecological Devices Market, North America, Revenue ($ m), 2005-2013

3.4 Gynecological Devices Market, North America, Revenue ($ m), 2013-2020

3.5 Gynecological Devices Market, North America, Volume (Units), 2005-2020

3.6 Gynecological Devices Market, North America, Volume (Units), 2005-2013

3.7 Gynecological Devices Market, North America, Volume (Units), 2013-2020

3.8 Gynecological Devices Market, North America, Company Share by Revenue ($ m), 2012-2013

4 Gynecological Devices Market, Canada

5 Gynecological Devices Market, Mexico

6 Gynecological Devices Market, United States

Explore more reports on Medical Devices industry at http://www.marketoptimizer.org/category/life-sciences/medical-devices .

About Us:

MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.







Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org


Dallas, Texas (PRWEB) September 17, 2014

“North America Gynecological Devices Market Outlook to 2020″, provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments –

Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings))
Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices)
Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge)
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available.

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10486 .

The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Complete Report Details Available @ http://www.marketoptimizer.org/north-america-gynecological-devices-market-outlook-to-2020.html .

Overview of Key Companies in North America Gynecological Devices Market:

Conceptus, Inc.
Hologic, Inc.
Boston Scientific Corporation
Cook Group Incorporated
CooperSurgical, Inc.
Merit Medical Systems, Inc.
Utah Medical Products, Inc.
Johnson & Johnson
BSD Medical Corporation
Scope

Market size data for Gynecological Devices market segments – Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge).
Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
2013 company shares and distribution shares data for Gynecological Devices market.
Global corporate-level profiles of key companies operating within the Gynecological Devices market.
Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical.
Reasons to buy

Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=10486 . (This is a premium report priced at US$ 3000 for a single user License.)

Major Points in Table of Content

3 Gynecological Devices Market, North America

3.1 Gynecological Devices Market, North America, Revenue ($ m), 2005-2020

3.2 Gynecological Devices Market, North America, Category Comparison by Revenue ($ m), 2005-2020

3.3 Gynecological Devices Market, North America, Revenue ($ m), 2005-2013

3.4 Gynecological Devices Market, North America, Revenue ($ m), 2013-2020

3.5 Gynecological Devices Market, North America, Volume (Units), 2005-2020

3.6 Gynecological Devices Market, North America, Volume (Units), 2005-2013

3.7 Gynecological Devices Market, North America, Volume (Units), 2013-2020

3.8 Gynecological Devices Market, North America, Company Share by Revenue ($ m), 2012-2013

4 Gynecological Devices Market, Canada

5 Gynecological Devices Market, Mexico

6 Gynecological Devices Market, United States

Explore more reports on Medical Devices industry at http://www.marketoptimizer.org/category/life-sciences/medical-devices .

About Us:

MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.







“YOUR SOARING PHOENIX” by Dr. Carol Francis Available Today 10% off Amazon


Los Angeles, CA (PRWEB) September 15, 2014

“YOUR SOARING PHOENIX” by Dr. Carol Francis and 25 other authors is available today on Amazon.com at 10% discount. These 26 authors and seasoned professionals of YOUR SOARING PHOENIX examine 42 experiences and exercises which inspire and instruct readers to expand their world-view and their personal beliefs about psychological power, ability to change personality and events, health and healing, practical every day use of metaphysical practices, and research about parapsychological tools. “Integrating empirical scientific data, metaphysical experiences and practices, along with personal growth techniques is reflected in the writings of these 26 authors and professionals. Each 42 chapters of YOUR SOARING PHOENIX aims to assist individuals to live and to think in a multi-disciplinary fashion as they expand their lives to be even more effective and enriching,” explains Clinical Psychologist and author Dr. Carol Francis.

“YOUR SOARING PHOENIX” today is available for 10% off both as paperback and ebook editions at Amazon.com or this link (click here).

About Contributing Authors:

Dr. Carol Francis, Clinical Psychologist, Marriage, Family and Child Counselor, Reiki Usui Master, Certified Medical Hypnotherapist practices in the Torrance, Redondo Beach, Manhattan Beach areas of Los Angeles providing services for over 37. “YOUR SOARING PHOENIX” is one of many books by Dr. Carol Francis including “Evolving Women’s Consciousness,” “Re-uniting Soldiers with Their Families,” and “If You Can’t Stop Eating, Maybe You’re Hungry.”

YOUR SOARING PHOENIX includes best selling authors such as:

Cynthia Sue Larson author of over 9 best selling books from Cal Berkeley with her recent release Quantum Jumps: An Extraordinary Science of Happiness and Prosperity

Raven Keyes who worked with Dr. Oz and author of Healing Power of Reiki

Michael Ortiz Hill nurse and cross-cultural writer of over 12 books including The Craft of Compassion

Dr. Marjorie Miles creator of site Journey of Your Dreams & author of Healing Haikus – A Poetic Prescription for Surviving Cancer and Clinical Hypnotherapist and survivor of cancer with the help of poetic expression

Dr. Shelley Stockwell Nicolas international speaker and author of over 26 best selling books with her most recent book released 2014: The Mysteries of You

Belinda Farrell author of Find Your Friggin’ Joy, actress and stunt car driver

Dr. Andrew Cort, Lawyer and Chiropractor, and author of Symbols, Meanings and the Sacred Quest

Dr. Steve G. Jones, Master Hypnotherapist, International Speaker and Creator of over 2000 tools for Self Improvement

Mary O’Maley producer of The Merry Medium Radio Show and Co-Editor of YOUR SOARING PHOENIX

Dr. Heather Friedman Rivera author of Quiet Waters and Healing the Present from the Past

Dr. Carolyn White author of Think It, Say It, Be It

Michael Lightweaver inspirational author of viral blogs

Donald Saunders author of the eye-opening series The Knowledge

Barbara Schiffman author of Akashic Records and LIVING IN BALANCE FOR BOOMERS: Secrets to Making the Most of the Second Half of Life

Edie Summers executive director of SMASHON, a world wide health practitioner’s referral system and author of Self-Coach Your Way to More Energy and her book about surviving CS: Memory of Health

Dennie Gooding world wide famous intuitive reader for government and private parties with her Masters in Engineering and Psychology

Actress, producer and international speaker Jane Sibbett

Brigit Esselmont, creator of the world wide used BiddyTarot.com

and many more professionals to be announced.







Breast Cancer Market (HER2-, HER2+) Epidemiology Forecast to 2023 in New Report Available at MarketOptimizer.org


Dallas, Texas (PRWEB) September 10, 2014

Epidemiologists forecast that the number of diagnosed incident cases of breast cancer in women in the 8MM is expected to grow to 1.21 million cases in 2023 at a rate of 4.23% per year during the forecast period. The number of five-year diagnosed prevalent cases in the 8MM is expected to increase by 43.0% over the next decade to 5.12 million cases in 2023.

Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body through the bloodstream and the lymphatic system. Prolonged exposure to endogenous and exogenous sex hormones, gene mutations, a family history of breast cancer, overweight and obesity, physical inactivity, a sedentary lifestyle, high alcohol consumption, early age at menarche (less than 12 years), late age at menopause (Greater Than 55 years), and clinical factors, such as biopsy-confirmed atypical hyperplasia, and having a high breast tissue and bone density are all risk factors for breast cancer.

Complete Report Details Available @ http://www.marketoptimizer.org/epicast-report-breast-cancer-her2-her2-epidemiology-forecast-to-2023.html .

Forecast is supported by at least 10 years of robust, country-specific historical data obtained from the WHO International Agency for Cancer Research’s (IARC’s) SurvCan, the Surveillance of Epidemiology and End Results Program Cancer Statistics Review 1975-2009, EUROCARE-4, research articles published in peer-reviewed journals, and the IARC’s Cancer Incidence in Five Continents Plus database, which provided detailed case segmentation by age and sex and is considered the gold standard for international comparison of country-specific data. Strength of this analysis is that epidemiologists compared the incident case projections with the estimates made by country-specific registries and the IARC, and found that the forecast numbers were in accordance with the international estimates.

Scope

    The Breast Cancer (HER2-, HER2+) EpiCast Report and EpiCast Model provide an overview of the risk factors, comorbidities, and the global and historical trends for breast cancer in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and urban China). In addition, the report also includes a 10-year forecast for the incident and the five-year prevalent cases of breast cancer in women segmented by age (20 to =85 years), natural menopausal status, cancer stage at diagnosis (local, regional, distant, unstaged), and hormone receptor subtypes: ER+ and/or PR+, HER2-; ER-, PR-, HER2+; ER+ and /or PR+, HER2+; and ER-, PR-, HER2- (triple negative).
    The breast cancer epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
    The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
    The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10411 .

Reasons to Buy

    Develop business strategies by understanding the trends shaping and driving the global breast cancer market.
    Quantify patient populations in the global breast cancer market to improve product design, pricing, and launch plans.
    Organize sales and marketing efforts by identifying the age groups, menopausal status, cancer stage, and hormone receptor subtypes that present the best opportunities for breast cancer therapeutics in each of the markets covered.

Major Points in Table of Contents

4 Epidemiology

4.1 Disease Background

4.2 Risk Factors and Comorbidities

4.2.1 A family history of breast cancer and BRCA1/2 gene mutations significantly increase the breast cancer risk

4.2.2 Reproductive hormonal factors influence the risk of breast cancer

4.2.3 Modifiable lifestyle-related factors increase the risk of mortality in breast cancer patients

4.2.4 Screening programs have been shown to reduce breast cancer mortality, although the benefits need to be carefully weighed against the risks

4.3 Global Trends

4.3.1 Incidence

4.3.2 Prevalence and Survival

4.4 Forecast Methodology

4.4.1 Sources Used

4.4.2 Sources Not Used

4.4.3 Forecast Assumptions and Methods

4.5 Epidemiological Forecast for Breast Cancer (2013–2023) – Diagnosed Incident Cases

4.5.1 Diagnosed Incident Cases of Breast Cancer

4.5.2 Diagnosed Incident Cases of Breast Cancer by Age

4.5.3 Diagnosed Incident Cases of Breast Cancer by Menopausal Status

4.5.4 Diagnosed Incident Cases of Breast Cancer Segmented by Stage at Diagnosis

4.5.5 Age-Standardized Diagnosed Incidence Rate of Breast Cancer

4.6 Epidemiological Forecast for Breast Cancer (2013–2023) — Diagnosed Prevalent Cases

4.6.1 Five-Year Diagnosed Prevalent Cases of Breast Cancer

4.6.2 Five-Year Diagnosed Prevalent Cases by Menopausal Status

4.6.3 Five-Year Diagnosed Prevalent Cases by Hormone Receptor Subtypes

Explore more reports on Pharmaceuticals industry at http://www.marketoptimizer.org/category/life-sciences/pharmaceuticals .

About Us:

MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.







Breast Cancer Market (HER2-, HER2+) Epidemiology Forecast to 2023 in New Report Available at MarketOptimizer.org


Dallas, Texas (PRWEB) September 10, 2014

Epidemiologists forecast that the number of diagnosed incident cases of breast cancer in women in the 8MM is expected to grow to 1.21 million cases in 2023 at a rate of 4.23% per year during the forecast period. The number of five-year diagnosed prevalent cases in the 8MM is expected to increase by 43.0% over the next decade to 5.12 million cases in 2023.

Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body through the bloodstream and the lymphatic system. Prolonged exposure to endogenous and exogenous sex hormones, gene mutations, a family history of breast cancer, overweight and obesity, physical inactivity, a sedentary lifestyle, high alcohol consumption, early age at menarche (less than 12 years), late age at menopause (Greater Than 55 years), and clinical factors, such as biopsy-confirmed atypical hyperplasia, and having a high breast tissue and bone density are all risk factors for breast cancer.

Complete Report Details Available @ http://www.marketoptimizer.org/epicast-report-breast-cancer-her2-her2-epidemiology-forecast-to-2023.html .

Forecast is supported by at least 10 years of robust, country-specific historical data obtained from the WHO International Agency for Cancer Research’s (IARC’s) SurvCan, the Surveillance of Epidemiology and End Results Program Cancer Statistics Review 1975-2009, EUROCARE-4, research articles published in peer-reviewed journals, and the IARC’s Cancer Incidence in Five Continents Plus database, which provided detailed case segmentation by age and sex and is considered the gold standard for international comparison of country-specific data. Strength of this analysis is that epidemiologists compared the incident case projections with the estimates made by country-specific registries and the IARC, and found that the forecast numbers were in accordance with the international estimates.

Scope

    The Breast Cancer (HER2-, HER2+) EpiCast Report and EpiCast Model provide an overview of the risk factors, comorbidities, and the global and historical trends for breast cancer in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and urban China). In addition, the report also includes a 10-year forecast for the incident and the five-year prevalent cases of breast cancer in women segmented by age (20 to =85 years), natural menopausal status, cancer stage at diagnosis (local, regional, distant, unstaged), and hormone receptor subtypes: ER+ and/or PR+, HER2-; ER-, PR-, HER2+; ER+ and /or PR+, HER2+; and ER-, PR-, HER2- (triple negative).
    The breast cancer epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
    The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
    The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10411 .

Reasons to Buy

    Develop business strategies by understanding the trends shaping and driving the global breast cancer market.
    Quantify patient populations in the global breast cancer market to improve product design, pricing, and launch plans.
    Organize sales and marketing efforts by identifying the age groups, menopausal status, cancer stage, and hormone receptor subtypes that present the best opportunities for breast cancer therapeutics in each of the markets covered.

Major Points in Table of Contents

4 Epidemiology

4.1 Disease Background

4.2 Risk Factors and Comorbidities

4.2.1 A family history of breast cancer and BRCA1/2 gene mutations significantly increase the breast cancer risk

4.2.2 Reproductive hormonal factors influence the risk of breast cancer

4.2.3 Modifiable lifestyle-related factors increase the risk of mortality in breast cancer patients

4.2.4 Screening programs have been shown to reduce breast cancer mortality, although the benefits need to be carefully weighed against the risks

4.3 Global Trends

4.3.1 Incidence

4.3.2 Prevalence and Survival

4.4 Forecast Methodology

4.4.1 Sources Used

4.4.2 Sources Not Used

4.4.3 Forecast Assumptions and Methods

4.5 Epidemiological Forecast for Breast Cancer (2013–2023) – Diagnosed Incident Cases

4.5.1 Diagnosed Incident Cases of Breast Cancer

4.5.2 Diagnosed Incident Cases of Breast Cancer by Age

4.5.3 Diagnosed Incident Cases of Breast Cancer by Menopausal Status

4.5.4 Diagnosed Incident Cases of Breast Cancer Segmented by Stage at Diagnosis

4.5.5 Age-Standardized Diagnosed Incidence Rate of Breast Cancer

4.6 Epidemiological Forecast for Breast Cancer (2013–2023) — Diagnosed Prevalent Cases

4.6.1 Five-Year Diagnosed Prevalent Cases of Breast Cancer

4.6.2 Five-Year Diagnosed Prevalent Cases by Menopausal Status

4.6.3 Five-Year Diagnosed Prevalent Cases by Hormone Receptor Subtypes

Explore more reports on Pharmaceuticals industry at http://www.marketoptimizer.org/category/life-sciences/pharmaceuticals .

About Us:

MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.







Breast Cancer Market (HER2-, HER2+) Epidemiology Forecast to 2023 in New Report Available at MarketOptimizer.org


Dallas, Texas (PRWEB) September 10, 2014

Epidemiologists forecast that the number of diagnosed incident cases of breast cancer in women in the 8MM is expected to grow to 1.21 million cases in 2023 at a rate of 4.23% per year during the forecast period. The number of five-year diagnosed prevalent cases in the 8MM is expected to increase by 43.0% over the next decade to 5.12 million cases in 2023.

Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body through the bloodstream and the lymphatic system. Prolonged exposure to endogenous and exogenous sex hormones, gene mutations, a family history of breast cancer, overweight and obesity, physical inactivity, a sedentary lifestyle, high alcohol consumption, early age at menarche (less than 12 years), late age at menopause (Greater Than 55 years), and clinical factors, such as biopsy-confirmed atypical hyperplasia, and having a high breast tissue and bone density are all risk factors for breast cancer.

Complete Report Details Available @ http://www.marketoptimizer.org/epicast-report-breast-cancer-her2-her2-epidemiology-forecast-to-2023.html .

Forecast is supported by at least 10 years of robust, country-specific historical data obtained from the WHO International Agency for Cancer Research’s (IARC’s) SurvCan, the Surveillance of Epidemiology and End Results Program Cancer Statistics Review 1975-2009, EUROCARE-4, research articles published in peer-reviewed journals, and the IARC’s Cancer Incidence in Five Continents Plus database, which provided detailed case segmentation by age and sex and is considered the gold standard for international comparison of country-specific data. Strength of this analysis is that epidemiologists compared the incident case projections with the estimates made by country-specific registries and the IARC, and found that the forecast numbers were in accordance with the international estimates.

Scope

    The Breast Cancer (HER2-, HER2+) EpiCast Report and EpiCast Model provide an overview of the risk factors, comorbidities, and the global and historical trends for breast cancer in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and urban China). In addition, the report also includes a 10-year forecast for the incident and the five-year prevalent cases of breast cancer in women segmented by age (20 to =85 years), natural menopausal status, cancer stage at diagnosis (local, regional, distant, unstaged), and hormone receptor subtypes: ER+ and/or PR+, HER2-; ER-, PR-, HER2+; ER+ and /or PR+, HER2+; and ER-, PR-, HER2- (triple negative).
    The breast cancer epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
    The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
    The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10411 .

Reasons to Buy

    Develop business strategies by understanding the trends shaping and driving the global breast cancer market.
    Quantify patient populations in the global breast cancer market to improve product design, pricing, and launch plans.
    Organize sales and marketing efforts by identifying the age groups, menopausal status, cancer stage, and hormone receptor subtypes that present the best opportunities for breast cancer therapeutics in each of the markets covered.

Major Points in Table of Contents

4 Epidemiology

4.1 Disease Background

4.2 Risk Factors and Comorbidities

4.2.1 A family history of breast cancer and BRCA1/2 gene mutations significantly increase the breast cancer risk

4.2.2 Reproductive hormonal factors influence the risk of breast cancer

4.2.3 Modifiable lifestyle-related factors increase the risk of mortality in breast cancer patients

4.2.4 Screening programs have been shown to reduce breast cancer mortality, although the benefits need to be carefully weighed against the risks

4.3 Global Trends

4.3.1 Incidence

4.3.2 Prevalence and Survival

4.4 Forecast Methodology

4.4.1 Sources Used

4.4.2 Sources Not Used

4.4.3 Forecast Assumptions and Methods

4.5 Epidemiological Forecast for Breast Cancer (2013–2023) – Diagnosed Incident Cases

4.5.1 Diagnosed Incident Cases of Breast Cancer

4.5.2 Diagnosed Incident Cases of Breast Cancer by Age

4.5.3 Diagnosed Incident Cases of Breast Cancer by Menopausal Status

4.5.4 Diagnosed Incident Cases of Breast Cancer Segmented by Stage at Diagnosis

4.5.5 Age-Standardized Diagnosed Incidence Rate of Breast Cancer

4.6 Epidemiological Forecast for Breast Cancer (2013–2023) — Diagnosed Prevalent Cases

4.6.1 Five-Year Diagnosed Prevalent Cases of Breast Cancer

4.6.2 Five-Year Diagnosed Prevalent Cases by Menopausal Status

4.6.3 Five-Year Diagnosed Prevalent Cases by Hormone Receptor Subtypes

Explore more reports on Pharmaceuticals industry at http://www.marketoptimizer.org/category/life-sciences/pharmaceuticals .

About Us:

MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.







Breast Cancer Market (HER2-, HER2+) Epidemiology Forecast to 2023 in New Report Available at MarketOptimizer.org


Dallas, Texas (PRWEB) September 10, 2014

Epidemiologists forecast that the number of diagnosed incident cases of breast cancer in women in the 8MM is expected to grow to 1.21 million cases in 2023 at a rate of 4.23% per year during the forecast period. The number of five-year diagnosed prevalent cases in the 8MM is expected to increase by 43.0% over the next decade to 5.12 million cases in 2023.

Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body through the bloodstream and the lymphatic system. Prolonged exposure to endogenous and exogenous sex hormones, gene mutations, a family history of breast cancer, overweight and obesity, physical inactivity, a sedentary lifestyle, high alcohol consumption, early age at menarche (less than 12 years), late age at menopause (Greater Than 55 years), and clinical factors, such as biopsy-confirmed atypical hyperplasia, and having a high breast tissue and bone density are all risk factors for breast cancer.

Complete Report Details Available @ http://www.marketoptimizer.org/epicast-report-breast-cancer-her2-her2-epidemiology-forecast-to-2023.html .

Forecast is supported by at least 10 years of robust, country-specific historical data obtained from the WHO International Agency for Cancer Research’s (IARC’s) SurvCan, the Surveillance of Epidemiology and End Results Program Cancer Statistics Review 1975-2009, EUROCARE-4, research articles published in peer-reviewed journals, and the IARC’s Cancer Incidence in Five Continents Plus database, which provided detailed case segmentation by age and sex and is considered the gold standard for international comparison of country-specific data. Strength of this analysis is that epidemiologists compared the incident case projections with the estimates made by country-specific registries and the IARC, and found that the forecast numbers were in accordance with the international estimates.

Scope

    The Breast Cancer (HER2-, HER2+) EpiCast Report and EpiCast Model provide an overview of the risk factors, comorbidities, and the global and historical trends for breast cancer in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and urban China). In addition, the report also includes a 10-year forecast for the incident and the five-year prevalent cases of breast cancer in women segmented by age (20 to =85 years), natural menopausal status, cancer stage at diagnosis (local, regional, distant, unstaged), and hormone receptor subtypes: ER+ and/or PR+, HER2-; ER-, PR-, HER2+; ER+ and /or PR+, HER2+; and ER-, PR-, HER2- (triple negative).
    The breast cancer epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
    The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
    The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10411 .

Reasons to Buy

    Develop business strategies by understanding the trends shaping and driving the global breast cancer market.
    Quantify patient populations in the global breast cancer market to improve product design, pricing, and launch plans.
    Organize sales and marketing efforts by identifying the age groups, menopausal status, cancer stage, and hormone receptor subtypes that present the best opportunities for breast cancer therapeutics in each of the markets covered.

Major Points in Table of Contents

4 Epidemiology

4.1 Disease Background

4.2 Risk Factors and Comorbidities

4.2.1 A family history of breast cancer and BRCA1/2 gene mutations significantly increase the breast cancer risk

4.2.2 Reproductive hormonal factors influence the risk of breast cancer

4.2.3 Modifiable lifestyle-related factors increase the risk of mortality in breast cancer patients

4.2.4 Screening programs have been shown to reduce breast cancer mortality, although the benefits need to be carefully weighed against the risks

4.3 Global Trends

4.3.1 Incidence

4.3.2 Prevalence and Survival

4.4 Forecast Methodology

4.4.1 Sources Used

4.4.2 Sources Not Used

4.4.3 Forecast Assumptions and Methods

4.5 Epidemiological Forecast for Breast Cancer (2013–2023) – Diagnosed Incident Cases

4.5.1 Diagnosed Incident Cases of Breast Cancer

4.5.2 Diagnosed Incident Cases of Breast Cancer by Age

4.5.3 Diagnosed Incident Cases of Breast Cancer by Menopausal Status

4.5.4 Diagnosed Incident Cases of Breast Cancer Segmented by Stage at Diagnosis

4.5.5 Age-Standardized Diagnosed Incidence Rate of Breast Cancer

4.6 Epidemiological Forecast for Breast Cancer (2013–2023) — Diagnosed Prevalent Cases

4.6.1 Five-Year Diagnosed Prevalent Cases of Breast Cancer

4.6.2 Five-Year Diagnosed Prevalent Cases by Menopausal Status

4.6.3 Five-Year Diagnosed Prevalent Cases by Hormone Receptor Subtypes

Explore more reports on Pharmaceuticals industry at http://www.marketoptimizer.org/category/life-sciences/pharmaceuticals .

About Us:

MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.







New Market Research Reports by Euromonitor International Now Available at MarketPublishers.com


London, UK (PRWEB) August 19, 2014

Market Publishers Ltd is happy to announce that new market research reports worked out by Euromonitor International Ltd have been added to its catalogue.

Pet Care in South Africa. Despite economic instability, provoked by rising household debt, unemployment, high fuel and food prices and Rand value decrease, the pet market in South Africa was on an upward trend during 2009-2013, growing at a CAGR of 8%. New product innovations and increasing unit price contributed to the market value growth. The cutting-edge report provides an in-depth insight into the pet market in South Africa, describing key companies, brands and competitors. It analyzes such market drivers, reviews product developments, gives pricing data and touches upon distribution issues. Future outlook till 2018 is also given.

Alcoholic Drinks in Portugal. Alcoholic drinks sales in Portugal have been declining since 2010. Many consumers cut their consumption of alcoholic drinks due to the reducing purchasing power. The recession continued in 2013, although it was not as sharp as in 2012. The novel research examines the alcoholic drinks sector in Portugal and unveils data on distribution, firms’ shares and market size. Moreover, the study provides the latest retail sales information and gives a comprehensive understanding of the competitive environment, reviews main market players and leading brands. Industry five-year forecast is presented, too.

Packaging Industry in Turkey. The packaging industry volume in Turkey faced a stable increase during 2013, given the growth in beverages, food and non-food segments. The large number of small households, increasing on-the-go food consumption and rising prevalence of small size packages led to further development of packaging sector in the country. The new report offers an extensive overview of the packaging market in Turkey, examines prospects and reviews trends for various packaging types. In addition, it uncovers data on the main firms, brands and competitors engaged in the industry. Market forecasts to 2018 are also at hand.

Beauty and Personal Care in Iran. The use of beauty and personal care products in Iran is growing now due to the advertising campaigns of leading companies and better availability of these products. Moreover, the growing consumption of sophisticated products instead of simple products contributes to the rise of the market value. The study offers all-round analysis of the personal care and beauty industry in Iran, covering main products, firms and brands. Besides, it includes data on market size, company shares and distribution channels. Retail sales information from 2009 till 2013, along with growth prospects through 2018 are given.

Tobacco in Ireland. Despite the tough economic period in Ireland, consumer sentiment was rather positive over 2008-2013 period. Still, cigarettes price in the country is currently the highest in Europe. After an excise increase in the budget in 2014, the cost of pack of 20 cigarettes increased by EUR 0.10. The novel research gives an extensive overview of the tobacco market in Ireland and provides data on main players and competitors. Furthermore, the report analyzes key factors driving the industry, touches upon the distribution, legislative and pricing issues. Tobacco market forecast till 2018 is provided.

More new studies by the publisher can be found at Euromonitor International page.